ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
-0.56%
US Tech 100
18,387.20
0.87%
S&P 500
5,307.01
-0.27%
US Dollar vs CAD
1.36764
-0.11%
Bitcoin
69,600.18
0.72%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Ginkgo Bioworks Holdings Inc (DNA)

  7. Ginkgo Bioworks Holdings Inc (DNA) News

DNA

Ginkgo Bioworks (DNA)

Ginkgo Bioworks Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:DNA
DateTimeSourceHeadlineSymbolCompany
05/22/20248:44AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/21/202410:02AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/20/20249:43AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/19/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:DNAGinkgo Bioworks Holdings Inc
05/17/20243:50PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:DNAGinkgo Bioworks Holdings Inc
05/17/20249:24AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/17/20249:24AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/17/20249:24AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/16/20249:31AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/15/202412:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/15/20246:01AMPR Newswire (US)Ginkgo Bioworks to Participate in Two Conferences in MayNYSE:DNAGinkgo Bioworks Holdings Inc
05/14/20245:00PMPR Newswire (US)Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in JapanNYSE:DNAGinkgo Bioworks Holdings Inc
05/14/20249:48AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/13/20243:14PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:DNAGinkgo Bioworks Holdings Inc
05/13/20243:05PMPR Newswire (US)Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSENYSE:DNAGinkgo Bioworks Holdings Inc
05/13/20249:50AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/10/20249:10AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/09/20244:16PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NYSE:DNAGinkgo Bioworks Holdings Inc
05/09/20243:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:DNAGinkgo Bioworks Holdings Inc
05/09/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:DNAGinkgo Bioworks Holdings Inc
05/09/20243:01PMPR Newswire (US)Ginkgo Bioworks Reports First Quarter 2024 Financial ResultsNYSE:DNAGinkgo Bioworks Holdings Inc
05/09/20249:13AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/08/20249:43AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/07/202410:40AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/07/20246:01AMPR Newswire (US)GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel SweetenerNYSE:DNAGinkgo Bioworks Holdings Inc
05/06/20243:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/06/20243:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/06/20249:43AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/06/20246:01AMPR Newswire (US)Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual MeetingNYSE:DNAGinkgo Bioworks Holdings Inc
05/02/20246:00AMPR Newswire (US)Ginkgo Bioworks Announces Date of First Quarter 2024 Results PresentationNYSE:DNAGinkgo Bioworks Holdings Inc
 Showing the most relevant articles for your search:NYSE:DNA

Your Recent History

BIT
UB30DK
UniCredit Bank
BIT
I07864
Intesa Sanpaolo
BIT
S29056
Societe Generale Effekten
BIT
P1WIQ4
NLBNPIT1WIQ4 20240920 1.14
BIT
P14Y59
BNP Paribas Issuance
TG
WOSB
Wolters Kluwers NV
BIT
P1WXZ4
NLBNPIT1WXZ4 20240920 30
COIN
SDAOETH
Singularity Dao
EU
ACAQJ
Credit Agricole SA Domes...
TG
BVF
Bausch Health Companies
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved